116 related articles for article (PubMed ID: 37470574)
1. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
2. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
[TBL] [Abstract][Full Text] [Related]
4. The clinical impacts of the prognostic nutritional index for the esophageal cancer patients who received curative treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102916
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-to-C-Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer.
Takeuchi M; Kawakubo H; Hoshino S; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
World J Surg; 2021 Nov; 45(11):3370-3377. PubMed ID: 34383091
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
[TBL] [Abstract][Full Text] [Related]
9. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
10. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
12. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Hara K; Maezawa Y; Hashimoto I; Suematsu H; Watanabe H; Komori K; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2023 Mar; 54(1):27-34. PubMed ID: 34921671
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
[TBL] [Abstract][Full Text] [Related]
15. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
Iseda N; Itoh S; Yoshizumi T; Tomiyama T; Morinaga A; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oda Y; Mori M
Int J Clin Oncol; 2021 Oct; 26(10):1890-1900. PubMed ID: 34251555
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
Eren T
ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Machida D; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Hara K; Segami K; Hashimoto I; Nagasawa S; Nakazono M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(3):1424-1431. PubMed ID: 35478112
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of lymphocyte/C-reactive protein ratio on postoperative outcomes in patients with rectal cancer who underwent curative resection.
Yamamoto T; Fukuda M; Okuchi Y; Oshimo Y; Nishikawa Y; Hisano K; Kawai T; Iguchi K; Okuda Y; Kamimura R; Tanaka E; Terajima H
Sci Rep; 2022 Oct; 12(1):17136. PubMed ID: 36229569
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
Aoyama T; Komori K; Nakazano M; Hara K; Tamagawa H; Kazama K; Hashimoto I; Yamada T; Maezawa Y; Segami K; Kano K; Nagasawa S; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2022; 36(2):942-948. PubMed ID: 35241553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
